The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Immunomedics
Leadership - Immunomedics
Stock and Other Ownership Interests - Immunomedics
Travel, Accommodations, Expenses - Immunomedics
Sacituzumab govitecan (SG) in patients (pts) with previously treated metastatic endometrial cancer (mEC): results from a phase I/II study.
 
Alessandro Santin
Consulting or Advisory Role - Merck; Tesaro
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Merck (Inst); Puma Biotechnology (Inst); R-Pharm (Inst); Tesaro (Inst)
 
Takefumi Komiya
Honoraria - Boehringer Ingelheim
Research Funding - AstraZeneca (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
David M. Goldenberg
Leadership - Immunomedics
Stock and Other Ownership Interests - Immunomedics; Immunomedics (I)
Patents, Royalties, Other Intellectual Property - Immunomedics
(OPTIONAL) Uncompensated Relationships - Center for Molecular Medicine and Immunology
 
Robert M. Sharkey
Stock and Other Ownership Interests - Immunomedics
Consulting or Advisory Role - Immunomedics
 
Quan Hong
Employment - Immunomedics
Leadership - Immunomedics
Stock and Other Ownership Interests - Immunomedics
Travel, Accommodations, Expenses - Immunomedics
 
William A. Wegener
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
 
Trishna Goswami
No Relationships to Disclose
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - bioTheranostics